✦ LIBER ✦

RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma

✍ Scribed by Mason, N J; Coughlin, C M; Overley, B; Cohen, J N; Mitchell, E L; Colligon, T A; Clifford, C A; Zurbriggen, A; Sorenmo, K U; Vonderheide, R H

Book ID: 109855132
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 313 KB
Volume: 15
Category: Article
ISSN: 0969-7128
DOI: 10.1038/gt.2008.22

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ex vivo induction of viral antigen-speci

Ex vivo induction of viral antigen-specific CD8+ T cell responses using mRNA-electroporated CD40-activated B cells

✍ G. A. Van den Bosch; P. Ponsaerts; G. Nijs; M. Lenjou; G. Vanham; D. R. Van Bock 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Induction of myeloma-specific cytotoxic

Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens

✍ Sang-Ki Kim; Thanh-Nhan Nguyen Pham; Tuyet Minh Nguyen Hoang; Hyun-Kyu Kang; Chu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 345 KB

CD154, a marker of antigen-specific stim

CD154, a marker of antigen-specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection

✍ J. F. Möller; B. Möller; B. Wiedenmann; T. Berg; E. Schott 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

IL-12p70 and IL-18 gene-modified dendrit

IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro

✍ Vujanovic, L; Ranieri, E; Gambotto, A; Olson, W C; Kirkwood, J M; Storkus, W J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB

Induction of carcinoembryonic antigen (c

Induction of carcinoembryonic antigen (cea)-specific cytotoxic t-lymphocyte responses In vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea

✍ Smita K. Nair; Shelley Hull; Doris Coleman; Eli Gilboa; H. Kim Lyerly; Michael A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies on the generation of potent DC capable of presenting tumor antigens such as carcinoembryonic antigen (CEA). It is unknown whether the T cells of patients with advanced malignancies can be reliably stimulat